Related Experiment Videos
Immune response products alter CNS activity: interferon modulates central opioid functions
N Dafny1, J R Lee, P M Dougherty
1Department of Neurobiology and Anatomy, University of Texas Medical School at Houston 77225.
Journal of Neuroscience Research
|January 1, 1988
Summary
Immune peptides like interferon-alpha (IFN-alpha) can signal the brain, altering central nervous system (CNS) activity. Direct brain injection of rIFN-alpha modified opiate withdrawal severity, supporting this immune-to-brain communication hypothesis.
Area of Science:
- Neuroimmunology
- Neuropharmacology
- Peptide signaling
Background:
- The immune system communicates with the central nervous system (CNS).
- Peptides released during immune responses may mediate this communication.
- Understanding this interaction is crucial for CNS disorders.
Purpose of the Study:
- To investigate if immune peptides alter CNS activity.
- To examine the effect of recombinant interferon-alpha (rIFN-alpha) on opiate withdrawal.
- To explore the neurophysiological basis of opioid and rIFN-alpha interactions.
Main Methods:
- Direct and systemic injection of rIFN-alpha in animal models.
- Dose-dependent assessment of opiate withdrawal severity.
- Electrophysiological recordings in brain structures.
Main Results:
- Direct brain injection of rIFN-alpha altered opiate withdrawal severity in a dose-dependent manner.
- Systemic rIFN-alpha administration showed different effects compared to direct injection.
- Electrophysiological data provided insights into opioid and rIFN-alpha interactions within CNS structures.
Conclusions:
- Immune peptides, such as rIFN-alpha, can directly influence CNS activity.
- The immune system may use peptides to transmit signals to the brain.
- rIFN-alpha's effects on CNS function warrant further investigation in the context of immune responses.